{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:01:47Z","timestamp":1792033307284,"version":"4.4.0"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Infections with Histoplasma can range from asymptomatic to life-threatening acute pulmonary or disseminated disease. Histoplasmosis can be challenging to diagnose and is widely underrecognized. We analyzed insurance claims data to better characterize histoplasmosis testing and treatment practices and its burden on patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used the IBM MarketScan Research Databases to identify patients with histoplasmosis (International Classification of Diseases, Ninth Revision, Clinical Modification codes 115.00\u2013115.99) during 2012\u20132014. We analyzed claims in the 3 months before to the 1 year after diagnosis and examined differences between patients with probable (hospitalized or &amp;gt;1 outpatient visit) and suspected (1 outpatient visit) histoplasmosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 1935 patients (943 probable, 992 suspected), 54% had codes for symptoms or findings consistent with histoplasmosis and 35% had \u22652 healthcare visits in the 3 months before diagnosis. Overall, 646 (33%) had any fungal-specific laboratory test: histoplasmosis antibody test (n = 349 [18%]), Histoplasma antigen test (n = 349 [18%]), fungal smear (n = 294 [15%]), or fungal culture (n = 223 [12%]); 464 (24%) had a biopsy. Forty-nine percent of probable patients and 10% of suspected patients were prescribed antifungal medication in the outpatient setting. In total, 19% were hospitalized. Patients\u2019 last histoplasmosis-associated healthcare visits occurred a median of 6 months after diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Some histoplasmosis patients experienced severe disease, apparent diagnostic delays, and prolonged illness, whereas other patients lacked symptoms and were likely diagnosed incidentally (eg, via biopsy). Low rates of histoplasmosis-specific testing also suggest incidental diagnoses and low provider suspicion, highlighting the need for improved awareness about this disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciz324","type":"journal-article","created":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T15:16:20Z","timestamp":1555946180000},"page":"1003-1010","source":"Crossref","is-referenced-by-count":32,"title":["Histoplasmosis-related Healthcare Use, Diagnosis, and Treatment in a Commercially Insured Population, United States"],"prefix":"10.1093","volume":"70","author":[{"given":"Kaitlin","family":"Benedict","sequence":"first","affiliation":[{"name":"Mycotic Diseases Branch, Centers for Disease Control and Prevention , Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlyn D","family":"Beer","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Centers for Disease Control and Prevention , Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan R","family":"Jackson","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Centers for Disease Control and Prevention , Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,4,30]]},"reference":[{"key":"2024111411410772900_CIT0001","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1378\/chest.29.6.649","article-title":"Geographic variation in the prevalence of histoplasmin sensitivity","volume":"29","author":"Manos","year":"1956","journal-title":"Dis Chest"},{"key":"2024111411410772900_CIT0002","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3201\/eid2410.180032","article-title":"Mapping Histoplasma capsulatum exposure, United States","volume":"24","author":"Maiga","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2024111411410772900_CIT0003","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3201\/eid2403.171258","article-title":"Multistate epidemiology of histoplasmosis, United States, 2011\u20132014","volume":"24","author":"Armstrong","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2024111411410772900_CIT0004","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.3201\/eid2111.141950","article-title":"Mycotic infections acquired outside areas of known endemicity, United States","volume":"21","author":"Benedict","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"2024111411410772900_CIT0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/tid.12186","article-title":"Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"16","author":"Kauffman","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"2024111411410772900_CIT0006","first-page":"39","article-title":"Clinical characteristics and outcomes in 303 HIV-infected patients with invasive fungal infections: data from the Prospective Antifungal Therapy Alliance registry, a multicenter, observational study","volume":"6","author":"Marukutira","year":"2014","journal-title":"HIV AIDS (Auckl)"},{"key":"2024111411410772900_CIT0007","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/cid\/civ299","article-title":"Histoplasmosis complicating tumor necrosis factor-\u03b1 blocker therapy: a retrospective analysis of 98 cases","volume":"61","author":"Vergidis","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2024111411410772900_CIT0008","doi-asserted-by":"crossref","first-page":"e0245","DOI":"10.1097\/MD.0000000000010245","article-title":"Central nervous system histoplasmosis: multicenter retrospective study on clinical features, diagnostic approach and outcome of treatment","volume":"97","author":"Wheat","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"2024111411410772900_CIT0009","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/CMR.00027-06","article-title":"Histoplasmosis: a clinical and laboratory update","volume":"20","author":"Kauffman","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"2024111411410772900_CIT0010","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.rmed.2012.02.004","article-title":"Endemic mycoses: overlooked causes of community acquired pneumonia","volume":"106","author":"Hage","year":"2012","journal-title":"Respir Med"},{"key":"2024111411410772900_CIT0011","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1532-5415.2011.03825.x","article-title":"Clinical presentation and management of histoplasmosis in older adults","volume":"60","author":"Ledtke","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"2024111411410772900_CIT0012","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1086\/521259","article-title":"Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America","volume":"45","author":"Wheat","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2024111411410772900_CIT0013","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3201\/eid2404.161568","article-title":"Testing for coccidioidomycosis among community-acquired pneumonia patients, southern California, USA","volume":"24","author":"Tartof","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2024111411410772900_CIT0014","doi-asserted-by":"crossref","first-page":"ofw078","DOI":"10.1093\/ofid\/ofw078","article-title":"Diagnostic delay and antibiotic overuse in acute pulmonary blastomycosis","volume":"3","author":"Alpern","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"2024111411410772900_CIT0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/gim.2013.66","article-title":"The use of US health insurance data for surveillance of rare disorders: hereditary hemorrhagic telangiectasia","volume":"16","author":"Grosse","year":"2014","journal-title":"Genet Med"},{"key":"2024111411410772900_CIT0016","doi-asserted-by":"crossref","first-page":"ofv219","DOI":"10.1093\/ofid\/ofv219","article-title":"Histoplasmosis-associated hospitalizations in the United States, 2001\u20132012","volume":"3","author":"Benedict","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"2024111411410772900_CIT0017","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/cid\/cir435","article-title":"A multicenter evaluation of tests for diagnosis of histoplasmosis","volume":"53","author":"Hage","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2024111411410772900_CIT0018","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1158\/1055-9965.EPI-18-0169","article-title":"Accuracy of a novel histoplasmosis enzyme immunoassay to evaluate suspicious lung nodules","volume":"28","author":"Deppen","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciz324\/28919065\/ciz324.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/70\/6\/1003\/32756932\/ciz324.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/70\/6\/1003\/32756932\/ciz324.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T07:28:01Z","timestamp":1731569281000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/70\/6\/1003\/5481778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,30]]},"references-count":18,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,4,30]]},"published-print":{"date-parts":[[2020,3,3]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciz324","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,3,15]]},"published":{"date-parts":[[2019,4,30]]}}}